Next Article in Journal
Identification of New Anti-SARS CoV-2 Agents through theVirtual Screening of Phytoconstituents Extracted from Moroccan Plants
Previous Article in Journal
Synthesis and Antifungal Activity of Thioxanthone Derivatives
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Fumiquinazoline-Related Alkaloids with Antibacterial, Anti-Biofilm and Efflux Pump Inhibition Properties †

by
Mariana C. Almeida
1,2,
Nikoletta Szemerédi
3,
Fernando Durães
1,2,
Diana I. S. P. Resende
1,2,*,
Paulo Martins da Costa
2,4,
Madalena Pinto
1,2,
Gabriella Spengler
3 and
Emília Sousa
1,2
1
Laboratório de Química Orgânica e Farmacêutica, Departamento de Ciências Químicas, Faculdade de Farmácia (FFUP), Universidade do Porto, R. Jorge de Viterbo Ferreira 228, 4050-313 Porto, Portugal
2
Centro Interdisciplinar de Investigação Marinha e Ambiental (CIIMAR), Terminal de Cruzeiros do Porto de Leixões, 4450-208 Matosinhos, Portugal
3
Department of Medical Microbiology, Albert Szent-Gyorgyi Health Center and Albert Szent-Gyorgyi Medical School, University of Szeged, 6725 Szeged, Hungary
4
Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Departamento de Produção Aquática, Universidade do Porto, R. Jorge de Viterbo Ferreira 228, 4050-313 Porto, Portugal
*
Author to whom correspondence should be addressed.
Presented at the 8th International Electronic Conference on Medicinal Chemistry, 1–30 November 2022; Available online: https://ecmc2022.sciforum.net/.
Med. Sci. Forum 2022, 14(1), 43; https://doi.org/10.3390/ECMC2022-13440
Published: 1 November 2022
(This article belongs to the Proceedings of The 8th International Electronic Conference on Medicinal Chemistry)

Abstract

:
With antimicrobial resistance reaching critical levels worldwide, the development of new compounds that are effective against resistant bacterial pathogens or that can potentiate the effect of known antibiotics is an urgent need. The formation of biofilms and the overexpression of efflux pumps are some of the most common causes of drug resistance. Previous work from our group has shown that alkaloids related to the fumiquinazolines have antibacterial potential. Herein we aimed to synthesize a small library of fumiquinazoline-related alkaloids and to study their antibacterial and anti-biofilm activities as well as their capacity to inhibit bacterial efflux pumps. To achieve these goals, two naturally occurring alkaloids, as well as several new derivatives, were synthesized through a multi-step synthetic pathway. The screening of their antibacterial activities was achieved by determination of the minimum inhibitory concentration of each compound against a panel of clinically relevant bacterial species. Several compounds exhibited promising activities against Gram-positive bacteria. Then, using the ethidium bromide accumulation assay, it was possible to identify some compounds with capacity to inhibit efflux pumps. Some of the synthesized alkaloids also showed anti-biofilm potential, reinforcing the idea that fumiquinazoline-related alkaloids can constitute a key strategy for fighting antimicrobial resistance.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ECMC2022-13440/s1.

Author Contributions

Conceptualization, E.S. and G.S.; methodology, M.C.A., F.D. and N.S.; software, M.C.A. and F.D.; validation, D.I.S.P.R., M.P., E.S., G.S. and P.M.d.C.; formal analysis, M.C.A., F.D., M.P., D.I.S.P.R., E.S., G.S. and P.M.d.C.; investigation, M.C.A., F.D., and N.S.; resources, G.S.; P.M.d.C. and M.P.; data curation, M.C.A. and F.D.; writing—original draft preparation, M.C.A. and F.D.; writing—review and editing, M.P., E.S., G.S., P.M.d.C. and D.I.S.P.R.; visualization, E.S., G.S., P.M.d.C., M.P. and D.I.S.P.R.; supervision, M.P., P.M.d.C. and D.I.S.P.R.; project administration, E.S.; funding acquisition, E.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by national funds through FCT (Foundation for Science and Technology) within the scope of Base Funding UIDB/04423/2020 and UIDP/04423/2020 (CIIMAR, Group of Natural Products and Medicinal Chemistry), projects EXPL/CTA-AMB/0810/2021, PTDC/CTA-AMB/0853/2021 and CHIRALBIO ACTIVE-PI-3RL-IINFACTS-2019 and by the Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement and through the ERDF, as a result of the project ATLANTIDA (reference NORTE-01-0145-FEDER-000040). Mariana C. Almeida acknowledges the BYT+ 2020/2021 scholarship to CIIMAR and the PhD grant (2021.05224.BD) to FCT. Fernando Durães acknowledges his PhD grant (SFRH/BD/144681/2019) to FCT.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Almeida, M.C.; Szemerédi, N.; Durães, F.; Resende, D.I.S.P.; Martins da Costa, P.; Pinto, M.; Spengler, G.; Sousa, E. Fumiquinazoline-Related Alkaloids with Antibacterial, Anti-Biofilm and Efflux Pump Inhibition Properties. Med. Sci. Forum 2022, 14, 43. https://doi.org/10.3390/ECMC2022-13440

AMA Style

Almeida MC, Szemerédi N, Durães F, Resende DISP, Martins da Costa P, Pinto M, Spengler G, Sousa E. Fumiquinazoline-Related Alkaloids with Antibacterial, Anti-Biofilm and Efflux Pump Inhibition Properties. Medical Sciences Forum. 2022; 14(1):43. https://doi.org/10.3390/ECMC2022-13440

Chicago/Turabian Style

Almeida, Mariana C., Nikoletta Szemerédi, Fernando Durães, Diana I. S. P. Resende, Paulo Martins da Costa, Madalena Pinto, Gabriella Spengler, and Emília Sousa. 2022. "Fumiquinazoline-Related Alkaloids with Antibacterial, Anti-Biofilm and Efflux Pump Inhibition Properties" Medical Sciences Forum 14, no. 1: 43. https://doi.org/10.3390/ECMC2022-13440

Article Metrics

Back to TopTop